{"id":"https://openalex.org/W9870577","doi":null,"title":"FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.","display_name":"FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W9870577","mag":"9870577","pmid":"https://pubmed.ncbi.nlm.nih.gov/20047159"},"language":"en","primary_location":{"id":"pmid:20047159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20047159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067672486","display_name":"Stefania Petrosino","orcid":"https://orcid.org/0000-0002-4263-3987","observed_orcids":["https://orcid.org/0000-0002-4263-3987"]},"institutions":[{"id":"https://openalex.org/I4210147106","display_name":"Istituto di Chimica Biomolecolare","ror":"https://ror.org/03wyf0g15","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210147106","https://openalex.org/I4210155236"]},{"id":"https://openalex.org/I4210155236","display_name":"National Research Council","ror":"https://ror.org/04zaypm56","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210155236"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefania Petrosino","raw_affiliation_strings":["Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, 80078, Pozzuoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, 80078, Pozzuoli, Naples, Italy","institution_ids":["https://openalex.org/I4210147106","https://openalex.org/I4210155236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007484138","display_name":"Vincenzo Di Marzo","orcid":"https://orcid.org/0000-0002-1490-3070","observed_orcids":["https://orcid.org/0000-0002-1490-3070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincenzo Di Marzo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":16.1195,"has_fulltext":false,"cited_by_count":184,"citation_normalized_percentile":{"value":0.99630492,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"11","issue":"1","first_page":"51","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fatty-acid-amide-hydrolase","display_name":"fatty acid amide hydrolase","score":0.9559999704360962},{"id":"https://openalex.org/keywords/monoacylglycerol-lipase","display_name":"monoacylglycerol lipase","score":0.9860000014305115},{"id":"https://openalex.org/keywords/faah-inhibitors","display_name":"FAAH inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/magl-inhibitors","display_name":"MAGL inhibitors","score":1.0},{"id":"https://openalex.org/keywords/endocannabinoids","display_name":"endocannabinoids","score":0.9549999833106995},{"id":"https://openalex.org/keywords/cannabinoid-receptors","display_name":"cannabinoid receptors","score":0.7519999742507935},{"id":"https://openalex.org/keywords/cb1-receptor","display_name":"CB1 receptor","score":0.722000002861023},{"id":"https://openalex.org/keywords/cb2-receptor","display_name":"CB2 receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.9070000052452087},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.9700000286102295},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.8529999852180481},{"id":"https://openalex.org/keywords/enzyme-inhibitor-design","display_name":"enzyme inhibitor design","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C46721173","wikidata":"https://www.wikidata.org/wiki/Q368952","display_name":"Endocannabinoid system","level":3,"score":0.9207186698913574},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.8144850730895996},{"id":"https://openalex.org/C2781144285","wikidata":"https://www.wikidata.org/wiki/Q21113274","display_name":"Fatty acid amide hydrolase","level":5,"score":0.8055799007415771},{"id":"https://openalex.org/C8051207","wikidata":"https://www.wikidata.org/wiki/Q4678003","display_name":"Monoacylglycerol lipase","level":4,"score":0.7996785640716553},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.6088128089904785},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.580939531326294},{"id":"https://openalex.org/C93248783","wikidata":"https://www.wikidata.org/wiki/Q21150595","display_name":"Cannabinoid receptor type 2","level":5,"score":0.5509226322174072},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.38273000717163086},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37426480650901794},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35728389024734497},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27134257555007935},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.09311670064926147}],"mesh":[{"descriptor_ui":"D000099252","descriptor_name":"Fatty Acid Amide Hydrolases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000581","descriptor_name":"Amidohydrolases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008994","descriptor_name":"Monoacylglycerol Lipases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D043885","descriptor_name":"Receptor, Cannabinoid, CB2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D063385","descriptor_name":"Cannabinoid Receptor Modulators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D063388","descriptor_name":"Endocannabinoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20047159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20047159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:9870577","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20047159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3082024945","https://openalex.org/W2026874594","https://openalex.org/W2128615732","https://openalex.org/W2136742883","https://openalex.org/W2338860458","https://openalex.org/W7056517260","https://openalex.org/W1998688963","https://openalex.org/W7097695362","https://openalex.org/W2155801131","https://openalex.org/W7160873903"],"abstract_inverted_index":{"Apart":[0],"from":[1],"their":[2,25],"widespread":[3],"recreational":[4],"abuse,":[5],"the":[6,10,29,36,52,55,66,73,76,80,82,88,106,113,128,137,145,196,206,215],"psychoactive":[7],"preparations":[8],"of":[9,31,54,65,75,79,90,115,130,139,150,171,181,200,210,220,222],"plant":[11],"Cannabis":[12],"sativa":[13],"and":[14,39,69,84,100,103,123,158,166,188,198,212,214,217],"its":[15],"major":[16,153,207],"psychotropic":[17,60],"component,":[18],"Delta9-tetrahydrocannabinol":[19],"(THC),":[20],"are":[21,109],"also":[22],"known":[23],"for":[24,33],"medicinal":[26],"properties.":[27],"Following":[28],"identification":[30,89],"receptors":[32,41,71],"THC":[34,99],"-":[35,42],"cannabinoid":[37,56,67],"CB1":[38,68,102],"CB2":[40,70,104],"in":[43,120,178],"mammals,":[44],"various":[45],"pharmaceutical":[46],"strategies":[47],"have":[48,155,174],"attempted":[49],"to":[50,87,126,143],"exploit":[51],"properties":[53,209,219],"system":[57],"while":[58],"minimizing":[59],"side":[61],"effects.":[62],"The":[63],"cloning":[64],"enabled":[72],"discovery":[74],"endogenous":[77],"agonists":[78],"receptors,":[81],"endocannabinoids,":[83],"eventually":[85],"led":[86],"enzymes":[91,142,154,173],"that":[92,108],"catalyze":[93],"endocannabinoid":[94],"inactivation.":[95],"Unlike":[96],"exogenously":[97],"administered":[98],"synthetic":[101],"agonists,":[105],"endocannabinoids":[107],"produced":[110],"endogenously":[111],"following":[112],"onset":[114],"several":[116,182],"pathologies":[117],"may":[118],"act":[119],"a":[121],"site-":[122],"time-specific":[124],"manner":[125],"minimize":[127],"consequences":[129],"such":[131],"conditions.":[132],"This":[133,203],"observation":[134],"has":[135],"suggested":[136],"possibility":[138],"targeting":[140],"endocannabinoid-degrading":[141],"prolong":[144],"precisely":[146],"regulated":[147],"pro-homeostatic":[148],"action":[149],"endocannabinoids.":[151],"Two":[152],"been":[156],"cloned":[157],"investigated":[159],"thoroughly:":[160],"fatty":[161],"acid":[162],"amide":[163],"hydrolase":[164],"(FAAH)":[165],"monoacylglycerol":[167],"lipase":[168],"(MAGL).":[169],"Inhibitors":[170],"these":[172,223],"demonstrated":[175],"therapeutic":[176],"benefit":[177],"animal":[179],"models":[180],"disorders,":[183],"including":[184],"neuropathic":[185],"pain,":[186],"anxiety":[187],"inflammatory":[189],"bowel":[190],"diseases,":[191],"as":[192,194],"well":[193],"against":[195],"proliferation":[197],"migration":[199],"cancer":[201],"cells.":[202],"review":[204],"describes":[205],"biochemical":[208],"FAAH":[211],"MAGL,":[213],"design":[216],"pharmacological":[218],"inhibitors":[221],"enzymes.":[224]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":25},{"year":2012,"cited_by_count":18}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}